For: | Dong H, Lu FE, Gao ZQ, Xu LJ, Wang KF, Zou X. Effects of emodin on treating murine nonalcoholic fatty liver induced by high caloric laboratory chaw. World J Gastroenterol 2005; 11(9): 1339-1344 [PMID: 15761972 DOI: 10.3748/wjg.v11.i9.1339] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i9/1339.htm |
Number | Citing Articles |
1 |
Xuemei Jia, Stephen Iwanowycz, Junfeng Wang, Fatma Saaoud, Fang Yu, Yuzhen Wang, Jun Hu, Saurabh Chatterjee, Qian Wang, Daping Fan. Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides. Experimental Biology and Medicine 2014; 239(8): 1025 doi: 10.1177/1535370214530247
|
2 |
Robert Domitrović, Iva Potočnjak. A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives. Archives of Toxicology 2016; 90(1): 39 doi: 10.1007/s00204-015-1580-z
|
3 |
Mengting Zhou, Naihua Hu, Meichen Liu, Ying Deng, Linfeng He, Chaocheng Guo, Xingtao Zhao, Yunxia Li. A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori Radix. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5462063
|
4 |
Tongxi Zhuang, Xinyi Gu, Nian Zhou, Lili Ding, Li Yang, Mingmei Zhou. Hepatoprotection and hepatotoxicity of Chinese herb Rhubarb (Dahuang): How to properly control the “General (Jiang Jun)” in Chinese medical herb. Biomedicine & Pharmacotherapy 2020; 127: 110224 doi: 10.1016/j.biopha.2020.110224
|
5 |
Thing-Fong Tzeng, Hung-Jen Lu, Shorong-Shii Liou, Chia Ju Chang, I-Min Liu. Emodin, a Naturally Occurring Anthraquinone Derivative, Ameliorates Dyslipidemia by Activating AMP-Activated Protein Kinase in High-Fat-Diet-Fed Rats. Evidence-Based Complementary and Alternative Medicine 2012; 2012: 1 doi: 10.1155/2012/781812
|
6 |
Jinmei Li, Lili Ding, Baoliang Song, Xu Xiao, Meng Qi, Qiaoling Yang, Qiming Yang, Xiaowen Tang, Zhengtao Wang, Li Yang. Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway. European Journal of Pharmacology 2016; 770: 99 doi: 10.1016/j.ejphar.2015.11.045
|
7 |
Raghdaa Al Zarzour, Mariam Ahmad, Mohd. Asmawi, Gurjeet Kaur, Mohammed Saeed, Majed Al-Mansoub, Sultan Saghir, Nasiba Usman, Dhamraa Al-Dulaimi, Mun Yam. Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague–Dawley Rats. Nutrients 2017; 9(7): 766 doi: 10.3390/nu9070766
|
8 |
Shaojie Wang, Xiaojie Li, Hongli Guo, Zihang Yuan, Tao Wang, Luyong Zhang, Zhenzhou Jiang. Emodin alleviates hepatic steatosis by inhibiting sterol regulatory element binding protein 1 activity by way of the calcium/calmodulin‐dependent kinase kinase–AMP‐activated protein kinase–mechanistic target of rapamycin–p70 ribosomal S6 kinase signaling pathway. Hepatology Research 2017; 47(7): 683 doi: 10.1111/hepr.12788
|
9 |
Anna Alisi, Anna Pastore, Sara Ceccarelli, Nadia Panera, Daniela Gnani, Giovannella Bruscalupi, Mara Massimi, Giulia Tozzi, Fiorella Piemonte, Valerio Nobili. Emodin Prevents Intrahepatic Fat Accumulation, Inflammation and Redox Status Imbalance During Diet-Induced Hepatosteatosis in Rats. International Journal of Molecular Sciences 2012; 13(2): 2276 doi: 10.3390/ijms13022276
|
10 |
Ruchi Badoni Semwal, Deepak Kumar Semwal, Sandra Combrinck, Alvaro Viljoen. Emodin - A natural anthraquinone derivative with diverse pharmacological activities. Phytochemistry 2021; 190: 112854 doi: 10.1016/j.phytochem.2021.112854
|
11 |
Menghao Wang, Fangchao Yuan, He Bai, Jie Zhang, Hao Wu, Kaiwen Zheng, Wenfeng Zhang, Mingyong Miao, Jianping Gong. SHMT2 Promotes Liver Regeneration Through Glycine-activated Akt/mTOR Pathway. Transplantation 2019; 103(7): e188 doi: 10.1097/TP.0000000000002747
|
12 |
Xu Yi, Li Long, Chunzhang Yang, Yingying Lu, Mingliang Cheng, Diego Calvisi. Maotai Ameliorates Diethylnitrosamine-Initiated Hepatocellular Carcinoma Formation in Mice. PLoS ONE 2014; 9(4): e93599 doi: 10.1371/journal.pone.0093599
|
13 |
Minjiang Wang, Ronghua Zhao, Wangen Wang, Xiaojian Mao, Jie Yu. Lipid regulation effects of Polygoni Multiflori Radix, its processed products and its major substances on steatosis human liver cell line L02. Journal of Ethnopharmacology 2012; 139(1): 287 doi: 10.1016/j.jep.2011.11.022
|
14 |
Xiaojie Li, Zhimeng Xu, Shaojie Wang, Hongli Guo, Sizhe Dong, Tao Wang, Luyong Zhang, Zhenzhou Jiang. Emodin ameliorates hepatic steatosis through endoplasmic reticulum–stress sterol regulatory element‐binding protein 1c pathway in liquid fructose‐feeding rats. Hepatology Research 2016; 46(3) doi: 10.1111/hepr.12538
|
15 |
Hui Dong, Fu-Er Lu, Zhi-Qiang Gao, Li-Jun Xu, Kai-Fu Wang, Xin Zou. Effects of emodin on treating murine nonalcoholic fatty liver induced by high caloric laboratory chaw. World Journal of Gastroenterology 2005; 11(9): 1339-1344 doi: 10.3748/wjg.v11.i9.1339
|
16 |
Alexander T. Sougiannis, Reilly T. Enos, Brandon N. VanderVeen, Kandy T. Velazquez, Brittany Kelly, Sierra McDonald, William Cotham, Ioulia Chatzistamou, Mitzi Nagarkatti, Daping Fan, E. Angela Murphy. Safety of natural anthraquinone emodin: an assessment in mice. BMC Pharmacology and Toxicology 2021; 22(1) doi: 10.1186/s40360-021-00474-1
|
17 |
Naihua Hu, Jie Liu, Xinyan Xue, Yunxia Li. The effect of emodin on liver disease -- comprehensive advances in molecular mechanisms. European Journal of Pharmacology 2020; 882: 173269 doi: 10.1016/j.ejphar.2020.173269
|
18 |
Wangen Wang, Yanran He, Pei Lin, Yunfei Li, Ruifen Sun, Wen Gu, Jie Yu, Ronghua Zhao. In vitro effects of active components of Polygonum Multiflorum Radix on enzymes involved in the lipid metabolism. Journal of Ethnopharmacology 2014; 153(3): 763 doi: 10.1016/j.jep.2014.03.042
|
19 |
Adeeb Shehzad, Shagufta Rehmat, Salman Ul-Islam, Rizwan Ahmad, Meneerah Aljafary, Noor A. Alrushaid, Ebtesam A. Al-Suhaimi. Lirioresinol B dimethyl ether inhibits NF-κB and COX-2 and activates IκBα expression in CCl4-induced hepatic fibrosis. BMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-2839-3
|
20 |
B. Anu Monisha, Niraj Kumar, Ashu Bhan Tiku. Anti-inflammatory Nutraceuticals and Chronic Diseases. Advances in Experimental Medicine and Biology 2016; 928: 47 doi: 10.1007/978-3-319-41334-1_3
|
21 |
Linyuan Yu, Yongliang Zhao, Yongli Zhao. Advances in the pharmacological effects and molecular mechanisms of emodin in the treatment of metabolic diseases. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1240820
|
22 |
Hui Dong, Fu-er Lu, Li Zhao. Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease. Chinese Journal of Integrative Medicine 2012; 18(2): 152 doi: 10.1007/s11655-012-0993-2
|
23 |
Warinda Susutlertpanya, Duangporn Werawatganon, Prasong Siriviriyakul, Naruemon Klaikeaw. Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPARγin a Rat Model. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/509057
|
24 |
Yudong Wang, Jianing Zhang, Zheng Xu, Guifang Zhang, Huijuan Lv, Xinben Wang, Guijing Xu, Xuefeng Li, Zhigang Yang, Haoliang Wang, Yongfu Wang, Hongfang Li, Yanbin Shi. Identification and action mechanism of lipid regulating components from Rhei Radix et rhizoma. Journal of Ethnopharmacology 2022; 292: 115179 doi: 10.1016/j.jep.2022.115179
|
25 |
Lu TU, AiLi WANG, ChangZhong REN, ZaiGui LI, Masayoshi SAITO. Antioxidant Activities and Protective Effects on Hyperlipidemic Mice of Chinese Oat Rice Wine. Japan Agricultural Research Quarterly: JARQ 2013; 47(2): 209 doi: 10.6090/jarq.47.209
|
26 |
Jing-Jing Ma, Tao Zhang, Ning Fang, Yan Zou, Qi-Hai Gong, Li-Mei Yu, Dai-Xiong Chen. Establishment of a cell-based drug screening model for identifying agonists of human peroxisome proliferator-activated receptor gamma (PPARγ). Journal of Pharmacy and Pharmacology 2012; 64(5): 719 doi: 10.1111/j.2042-7158.2012.01462.x
|
27 |
Pei-Min Chao, Yueh-Hsiung Kuo, Yu-Shun Lin, Chi-Hua Chen, Shiow-Wen Chen, Yao-Haur Kuo. The Metabolic Benefits of Polygonum hypoleucum Ohwi in HepG2 Cells and Wistar Rats under Lipogenic Stress. Journal of Agricultural and Food Chemistry 2010; 58(8): 5174 doi: 10.1021/jf100046h
|
28 |
Huan Liu, Zhaolin Sun, Xiaoting Tian, Qin Feng, Ziqiong Guo, Shuoji Chen, Hao Yin, Yangyang Wang, Zhou Xu, Like Xie, Pei Hu, Chenggang Huang. Systematic investigation on the chemical basis of anti‐NAFLD Qushi Huayu Fang. Part 1: A study of metabolic profiles in vivo and in vitro by high‐performance liquid chromatography–quadrupole time‐of‐flight mass spectrometry. Biomedical Chromatography 2020; 34(5) doi: 10.1002/bmc.4805
|
29 |
Nan Wang, Hui Dong, Shichao Wei, Fuer Lu. Application of proton magnetic resonance spectroscopy and computerized tomography in the diagnosis and treatment of nonalcoholic fatty liver disease. Journal of Huazhong University of Science and Technology [Medical Sciences] 2008; 28(3): 295 doi: 10.1007/s11596-008-0315-2
|
30 |
Xin Fu, Ai‐guo Xu, Meng‐ying Yao, Li Guo, Luo‐sha Zhao. Emodin enhances cholesterol efflux by activating peroxisome proliferator‐activated receptor‐γ in oxidized low density lipoprotein‐loaded THP1 macrophages. Clinical and Experimental Pharmacology and Physiology 2014; 41(9): 679 doi: 10.1111/1440-1681.12262
|
31 |
Xiao-yan Xing, Yan-ling Zhao, Wei-jun Kong, Jia-bo Wang, Lei Jia, Ping Zhang, Dan Yan, Yan-wei Zhong, Rui-sheng Li, Xiao-he Xiao. Investigation of the “dose–time–response” relationships of rhubarb on carbon tetrachloride-induced liver injury in rats. Journal of Ethnopharmacology 2011; 135(2): 575 doi: 10.1016/j.jep.2011.03.053
|
32 |
Yutian Wang, Junzi Wu, Anhua Shi. Literature Review on the Use of Herbal Extracts in the Treatment of Non-
Alcoholic Fatty Liver Disease. Endocrine, Metabolic & Immune Disorders - Drug Targets 2022; 22(11): 1123 doi: 10.2174/1871530322666220408123746
|
33 |
Ying-Rong LENG, Mei-Hui ZHANG, Jian-Guang LUO, Hao ZHANG. Pathogenesis of NASH and Promising Natural Products. Chinese Journal of Natural Medicines 2021; 19(1): 12 doi: 10.1016/S1875-5364(21)60002-X
|
34 |
Hong-Liang Liang, Qin Ouyang. A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis. World Journal of Gastroenterology 2008; 14(1): 114-119 doi: 10.3748/wjg.14.114
|